Open Access
| Numéro |
Med Sci (Paris)
Volume 39, Numéro 4, Avril 2023
|
|
|---|---|---|
| Page(s) | 319 - 322 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2023038 | |
| Publié en ligne | 24 avril 2023 | |
- Wang B, Zhuang R, Luo X, et al. Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults worldwide: A meta-analysis. Horm Metab Res 2015 ; 47 : 839–845. [CrossRef] [PubMed] [Google Scholar]
- Lien EC, Westermark AM, Zhang Y, et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature 2021; 599 : 302–7. [CrossRef] [PubMed] [Google Scholar]
- Bastin J, Djouadi F. Effet des régimes hypoglycémiants sur la croissance tumorale : un rôle des lipides ? Med Sci (Paris) 2022; 38 : 526–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Rahman MS, Murphy AJ, Woollard KJ. Effects of dyslipidaemia on monocyte production and function in cardiovascular disease. Nat Rev Cardiol 2017 ; 14 : 387–400. [CrossRef] [PubMed] [Google Scholar]
- Deng T, Lyon CJ, Bergin S, et al. Obesity, inflammation, and cancer. Annu Rev Pathol Mech Dis 2016 ; 11 : 421–449. [CrossRef] [PubMed] [Google Scholar]
- Van’t Klooster CC, Ridker PM, Hjortnaes J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J 2019 ; 40 : 3901–3909. [CrossRef] [PubMed] [Google Scholar]
- Jiang H, Gebhardt C, Umansky L, et al. Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients. Int J Cancer 2015 ; 136 : 2352–2360. [CrossRef] [PubMed] [Google Scholar]
- Tran T, Lavillegrand J-R, Lereverend C, et al. Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells. Nat Commun 2022; 13 : 5399. [CrossRef] [PubMed] [Google Scholar]
- Koelwyn GJ, Newman AAC, Afonso MS, et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med 2020; 26 : 1452–8. [CrossRef] [PubMed] [Google Scholar]
- Potteaux S, Tedgui A. L’infarctus du myocarde accentue le phénotype immunosuppresseur et pro-tumoral des monocytes inflammatoires : un mécanisme d’aggravation du cancer par les maladies cardiovasculaires. Med Sci (Paris) 2021; 37 : 706–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Broadfield LA, Pane AA, Talebi A, et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell 2021; 56 : 1363–93. [CrossRef] [PubMed] [Google Scholar]
- McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 2018 ; 19 : 310–322. [CrossRef] [PubMed] [Google Scholar]
- Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med 2019 ; 25 : 141–151. [CrossRef] [PubMed] [Google Scholar]
- Karayama M, Inui N, Inoue Y, et al. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 2022; 71 : 203–17. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.